Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 178
Filtrar
1.
ABCS health sci ; 49: [1-9], 11 jun. 2024.
Artigo em Inglês | LILACS-Express | LILACS | ID: biblio-1555504

RESUMO

Introduction: Uncaria tomentosa (Willd. ex Roem. & Schult.) DC. (Rubiaceae) or UT is a medicinal plant with antiviral, antimutagenic, anti-inflammatory and antioxidant properties. Duchenne muscular dystrophy (DMD) is a severe muscle wasting disease caused by mutations in the dystrophin gene; this deficiency leads to sarcolemma instability, inflammation, muscle degeneration and fibrosis. Objective: Considering the importance of inflammation to dystrophy progression and the anti-inflammatory activity of UT, in the present study we evaluated whether oral administration of UT extract would ameliorate dystrophy in the mdx mice, a DMD model. Methods: Eight-week-old male mdx mice were submitted to 200 mg/kg body weight daily UT oral administration for 6 weeks. General histopathology was analysed, and muscle tumor necrosis factor α, transforming growth factor-ß, myostatin and osteopontin transcript levels were assessed. The ability of mice to sustain limb tension to oppose their gravitational force was measured. Data were analysed with the unpaired Student's t-test. Results: Morphologically, both untreated and UT-treated animals exhibited internalised nuclei, increased endomysial connective tissue and variations in muscle fibre diameters. Body weight and muscle strength were significantly reduced in the UT-treated animals. Blood creatine kinase was higher in UT-treated compared to untreated animals. In tibialis anterior, myostatin, transcript was more highly expressed in the UT-treated while in the diaphragm muscle, transforming growth factor-ß transcripts were less expressed in the UT-treated. Conclusion: While previous studies identified anti-inflammatory, antiproliferative and anticarcinogenic UT effects, the extract indicates worsening of dystrophic muscles phenotype after short-term treatment in mdx mice.

2.
Fisioter. Mov. (Online) ; 37: e37110, 2024. tab, graf
Artigo em Inglês | LILACS-Express | LILACS | ID: biblio-1534462

RESUMO

Abstract Introduction: Duchenne muscular dystrophy (DMD) is a recessive genetic disease linked to the X chromosome, leading to progressive muscle tissue loss. Initially, there is difficulty getting up from the floor and an increased frequency of falls. Maintaining ambulation as long as possible is essential, and the use of ankle-foot orthosis (AFO) has been investigated as an ally in this process. Objective: To verify the prescription and use of an AFO for ambulant boys with DMD. Methods: Information was collected using the medical records of 181 patients with DMD from the Neuropediatric Service of the Instituto de Puericultura e Pediatria Martagão Gesteira of the Universidade Federal do Rio de Janeiro. Variables used were: age at the first medical appointment, age at first symptoms, age at loss of independent gait, time between the first symptoms and loss of gait, prescription of orthosis, time of use, and surgical intervention in the lower limbs. Results: The orthosis was prescribed for 63.5% of patients and used by 38.1%. The range of orthosis time was 2 to 4 years (62.3%). The night sleep period was the most prescribed for orthosis use, with 67.2%. Patients who used the orthosis for a longer time were older at gait loss. However, the children who arrived earlier for the first appointment had a higher frequency of orthosis prescriptions and later loss of gait. Conclusion: The use of AFO can help maintain ambulation for longer in boys with DMD.


Resumo Introdução: A distrofia muscular de Duchenne (DMD) é uma doença genética recessiva ligada ao cromossomo X, que cursa com a perda progressiva do tecido muscular. Inicialmente, observa-se dificuldade para levantar do chão e aumento dafrequência de quedas. A manutenção da deambulação pelo maior tempo possível é importante e o uso de órtese tornozelo-pé (OTP) tem sido investigado como aliado nesse processo. Objetivo: Verificar a prescrição e uso de OTP para meninos deambulantes com DMD. Métodos: As informações foram coletadas dos prontuários de 181 pacientes com DMD do Serviço de Neuropediatria do Instituto de Puericultura e Pediatria Martagão Gesteira, da Universidade Federal do Rio de Janeiro. As variáveis utilizadas foram: idade na primeira consulta, idade aos primeiros sintomas, idade na perda da marcha independente, tempo entre os primeiros sintomas e a perda da marcha, prescrição de órtese, tempo de uso e intervenção cirúrgica nos membros inferiores. Resultados: A órtese foi prescrita para 63,5% dos pacientes e utilizada por 38,1%. A variação do tempo de uso foi de 2 a 4 anos (62,3%). O período noturno foi o mais prescrito para uso da órtese, com 67,2%. Os pacientes que a usaram por mais tempo apresentaram maiores idades na perda da marcha. Crianças que chegaram mais precocemente à primeira consulta tiveram maior frequência de prescrição de órtese e perda da marcha mais tardiamente. Conclusão: O uso de OTP pode ajudar a manter a deambulação por mais tempo em meninos com DMD.

3.
Estud. pesqui. psicol. (Impr.) ; 23(1): 180-204, maio 2023.
Artigo em Português | LILACS, INDEXPSI | ID: biblio-1434516

RESUMO

A Distrofia Muscular de Duchenne (DMD) é uma doença neuromuscular progressiva recessiva causada por mutações genéticas ligadas ao cromossomo X. Além do enfraquecimento muscular progressivo, a condição é associada a alterações neuropsicológicas. O objetivo deste estudo foi realizar uma revisão sistematizada da temática, para investigar os aspectos cognitivos e comportamentais associados à DMD pela literatura, nos últimos dez anos (2011-2021). Realizou-se uma revisão integrativa da literatura, com o propósito de sintetizar e analisar o conhecimento sobre o tema no campo científico, sendo efetuada busca nas bases de dados e motores de busca Science Direct, SciELO, PubMed e BVS. Após consideração dos critérios de inclusão e exclusão, foram selecionados 29 artigos para análise. Os resultados endossaram que alterações cognitivas e do neurodesenvolvimento, bem como de problemas comportamentais parecem ser mais prováveis na DMD, em comparação com a população geral. Verificou-se escassez de estudos empíricos brasileiros e a necessidade de avaliar e intervir nos âmbitos neuropsicológico e psicossocial, de forma precoce, contínua e multidisciplinar, no intuito de atender às necessidades desse grupo.


Duchenne Muscular Dystrophy (DMD) is a recessive progressive neuromuscular disease caused by X-linked genetic mutations. In addition to progressive muscle weakness, the condition is associated with neuropsychological alterations. The aim of this study was to perform a systematic review about the theme, to investigate the cognitive and behavioral aspects associated with DMD in the literature, over the last ten years (2011-2021). An integrative literature review was carried out, with the purpose of synthesizing and analyzing the knowledge on the subject in the scientific field, with a search in the databases and search engines Science Direct, SciELO, PubMed and BVS. After considering the inclusion and exclusion criteria, 29 articles were selected for analysis. The results endorsed that cognitive and neurodevelopmental alterations and behavioral problems seem to be more likely in DMD, when compared to the general population. There was a lack of brazilian empirical studies and the need to assess and intervene in the neuropsychological and psychosocial spheres was observed, in an early, continuous and multidisciplinary way, in order to meet the needs of this group.


La distrofia muscular de Duchenne (DMD) es una enfermedad neuromuscular progresiva recesiva causada por mutaciones genéticas ligadas al cromosoma X. Además de la debilidad muscular progresiva, la afección se asocia con cambios neuropsicológicos. El objetivo de este estudio fue realizar una revisión sistemática del tema, para investigar los aspectos cognitivos y conductuales asociados a la DMD en la literatura, en los últimos diez años (2011-2021). Se realizó una revisión integradora de la literatura, con el propósito de sintetizar y analizar el conocimiento sobre el tema en el campo científico, mediante una búsqueda en las bases de datos y motores de búsqueda Science Direct, SciELO, PubMed y BVS. Después de considerar los criterios de inclusión y exclusión, se seleccionaron 29 artículos para su análisis. Los resultados respaldaron que alteraciones cognitivas y del neurodesarrollo, así como problemas del comportamiento parecen ser más probables en la DMD en comparación con la población general. Se observó la escasez de estudios empíricos brasileños, así como la necesidad de evaluar e intervenir en los ámbitos neuropsicológico y psicosocial, de forma precoz, continua y multidisciplinar, para atender las necesidades de esta población.


Assuntos
Transtornos Cognitivos , Distrofia Muscular de Duchenne , Transtornos Mentais , Deficiências da Aprendizagem
4.
Medicina (B.Aires) ; 83(1): 52-58, abr. 2023. graf
Artigo em Inglês | LILACS-Express | LILACS | ID: biblio-1430772

RESUMO

Abstract Objective: To analyze the underlying components of reduced maximal static inspiratory (MIP) and expiratory (MEP) pressures in subjects with Duchenne muscular dystrophy. Methods: Forty-three subjects were assessed based on routine pulmonary function tests. MIP and MEP were measured the subjects performed maximal expirations and inspirations using a snorkel mouthpiece. Lung volumes were measured us ing the helium dilution technique. Results: The mean age was 13 years (range, 7-20 years). Median total lung capacity (TLC) and residual volume (RV) were 78.0 (49.0-94.0) and 27.0 (19.7-30.1) of the predicted values re spectively. The RV/TLC relationship was 35.3% (28.1-47.7). Thirty-five subjects had a TLC below the lower limit of normal, while 31 had an RV/TLC ratio above the upper limit of normal. The median (IQR) MIP and MEP values were -53.0 (-65.5 to -41.8) and 58.0 (41.5-74.8) cmH2O respectively. MIP and MEP in percent of the predicted values (predicted TLC and RV) were 42.6 (33.3-50.8) and 33.7 (23.9-44.5). MIP in percent of the RV reached for Group A (7-11 years old) was higher (p 0.025) while MEP in percent of the TLC reached for Group B (12-16 years) and C (17-20 years) were higher too (0.031). Conclusions: In subjects with Duchenne muscular dystrophy, the intrinsic weakness of respiratory muscles and mechanical disadvantage lead to inadequate maximal static pressure generation. Maximal static pressures should be interpreted cautiously as they overestimate respiratory muscle weakness when compared to predicted values obtained at TLC and RV. Our results provide additional data supporting absolute values use rather than predicted values.


Resumen Objetivo: Analizar los componentes subyacentes de las presiones inspiratorias (MIP) y espiratorias (MEP) es táticas máximas reducidas en sujetos con distrofia de Duchenne (DMD). Métodos: Se evaluaron 43 pacientes mediante pruebas de función pulmonar rutinarias. MIP y MEP fueron medidas a inspiración y espiración máximas. Los volúmenes pulmonares se midieron mediante dilución de helio. Resultados: Edad media 13 años (rango 7-20 años). La capacidad pulmonar total (TLC) y el volumen residual (RV) fueron 78.0% (49.0-94.0) y 27.0% (19.7- 30.1) de los valores predichos. El RV/TLC fue de 35.3% (28.1-47.7). Treinta y cinco sujetos tenían una TLC por debajo del límite inferior de normalidad, 31 tenían una RV/TLC por encima del límite superior de la normalidad. MIP y MEP fueron -53.0 (-65.5 a -41.8) y 58.0 (41.5-74.8) cmH2O, mientras que en % de los predichos (TLC y RV predichos) fueron 42.6 (33.3-50.8) y 33.7 (23.9-44.5). MIP en % del RV alcanzado (Grupo A 7-11 años) fue mayor (p 0.025), y MEP en % de la TLC alcanzada Grupo B (12-16 años) y C (17-20 años), también fue mayor (0.031). Conclusiones: En sujetos con DMD, debilidad intrínseca de los músculos respiratorios y desventaja mecánica conducen a generación de presión estática máxima inadecuada. Las mismas deben interpretarse con cautela, ya que sobrestiman la debilidad de los músculos respiratorios si se las compara con las tablas de valores predichos obtenidos a TLC y RV. Nuestros resultados proporcionan datos adicionales que respaldan la utilización de valores absolutos en lugar de los predichos.

5.
Artigo | IMSEAR | ID: sea-226515

RESUMO

Duchenne muscular dystrophy is one of the most common dystrophinopathies known. It is the most common hereditary neuromuscular disorder and is inherited in an X-linked recessive manner. Incidence is 1:3500 live male infants, characterised by progressive weakness of a selective group of muscles without involvement of nervous system. Age of onset being 3-10 years, many children unable to walk before 18 months of age. The patient usually dies by 18-20 years of age. 80% carries have high CPK values with female being the one. Dystrophin gene is the largest human gene with 79 exons, codes for protein dystrophin required for stabilisation of protein complex at sarcolemma, the abnormal DMD gene is on X chromosome at Xp21 locus. Dystrophin deficiency thus, leads to destruction of muscle fibres and progressive muscular weakness. Corticosteroids are the only medications that have shown to alter the course of DMD but have side effects like weight gain, decreased appetite, increase changes of cataract and osteoporosis. The present study is about management 8 years old male child with B/L lower limb weakness and calf muscle hypertrophy.etc, so according to Ayurvedic management with Panchkarma procedures and internal medicines given the case was managed. Successful improvement in CPK values along with the signs and symptoms was observed. As per Ayurvedic Siddhant and Samprapti application considering Adibalapravrittavyadhi and the Beejabhaga avayava dushti the management done. There is no treatment in any system of medicine and prognosis being unpreventable, Ayurveda instills a regenerative mechanism in neuromuscular disorders with special concern of Panchkarma, Rasayanas, Rasa aushadhi, etc. By this the deterioration can effectively be prolonged and quality of life improved.

6.
Biol. Res ; 56: 29-29, 2023. ilus, graf
Artigo em Inglês | LILACS | ID: biblio-1513741

RESUMO

BACKGROUND: Duchenne muscular dystrophy (DMD) is an X-linked lethal genetic disorder for which there is no effective treatment. Previous studies have shown that stem cell transplantation into mdx mice can promote muscle regeneration and improve muscle function, however, the specific molecular mechanisms remain unclear. DMD suffers varying degrees of hypoxic damage during disease progression. This study aimed to investigate whether induced pluripotent stem cells (iPSCs) have protective effects against hypoxia-induced skeletal muscle injury. RESULTS: In this study, we co-cultured iPSCs with C2C12 myoblasts using a Transwell nested system and placed them in a DG250 anaerobic workstation for oxygen deprivation for 24 h. We found that iPSCs reduced the levels of lactate dehydrogenase and reactive oxygen species and downregulated the mRNA and protein levels of BAX/BCL2 and LC3II/ LC3I in hypoxia-induced C2C12 myoblasts. Meanwhile, iPSCs decreased the mRNA and protein levels of atrogin-1 and MuRF-1 and increased myotube width. Furthermore, iPSCs downregulated the phosphorylation of AMPKA and ULK1 in C2C12 myotubes exposed to hypoxic damage. CONCLUSIONS: Our study showed that iPSCs enhanced the resistance of C2C12 myoblasts to hypoxia and inhibited apoptosis and autophagy in the presence of oxidative stress. Further, iPSCs improved hypoxia-induced autophagy and atrophy of C2C12 myotubes through the AMPK/ULK1 pathway. This study may provide a new theoretical basis for the treatment of muscular dystrophy in stem cells.


Assuntos
Animais , Camundongos , Proteínas Quinases Ativadas por AMP/metabolismo , Células-Tronco Pluripotentes Induzidas , Atrofia/metabolismo , Atrofia/patologia , Autofagia , RNA Mensageiro/metabolismo , Camundongos Endogâmicos mdx , Músculo Esquelético/metabolismo , Fibras Musculares Esqueléticas/metabolismo , Hipóxia/metabolismo
7.
International Journal of Pediatrics ; (6): 435-438, 2023.
Artigo em Chinês | WPRIM | ID: wpr-989107

RESUMO

Duchenne muscular dystrophy(DMD)is an X-linked recessive muscular disorder that affects mainly males.With its low incidence, insidious onset, and rapid progression, DMD is characterized by proximal muscle weakness, gastrocnemius hypertrophy, and markedly elevated serum creatine kinase.In addition to severe motor dysfunction, it also causes cardiac involvement in children, mainly manifested as dilated cardiomyopathy and arrhythmias.The mutations of DMD gene lead to the absence of dystrophin, which results in cytoskeletal defects and the impairment of the integrity of myocardial cell membrane.Meanwhile, calcium overload makes the myocytes more susceptible to damage.Exon deletion is the most common type of gene mutations in children with DMD, followed by point mutations, duplications and small insertion or deletion.The relationship among the clinical manifestations, pathogenesis, evaluation of cardiac damage in DMD and its genotype has not been clarified, which still needs further research and exploration, although some advances have been made recently.

8.
Artigo | IMSEAR | ID: sea-219444

RESUMO

Duchenne Muscular Dystrophy (DMD) is a genetic disorder involving progressive muscle deterioration leading to loss of mobility, cardiomyopathy, and respiratory complications leading to an early death by the fourth decade of life. Males are affected more often as DMD results from a mutation in the dystrophin gene residing on the X chromosome. The DMD genetic mutation results in a complete functional lack of dystrophin, which culminates as an inadequate connection between the intracellular actin filaments and the extracellular skeleton of muscle. Boys affected by DMD clinically present with muscle weakness before age five, are often wheelchair-bound by age 12, and rarely survive beyond the third decade of life. Traditional treatment strategies have focused primarily on quality-of-life improvement and have included the use of glucocorticoids and physical therapy. No cure currently exists, however many novel treatments for DMD are currently being explored. Some of these involve gene therapy, exon skipping, stop codon skipping, CRISPR technology interventions, and the use of a retinal dystrophin isoform. In this comprehensive review, we recapitulate the literature findings to summarize the history, epidemiology, genetics, clinical presentation, diagnosis, and current and future strategies for the treatment of Duchenne Muscular Dystrophy.

9.
Bol. méd. Hosp. Infant. Méx ; 79(5): 275-283, Sep.-Oct. 2022. graf
Artigo em Inglês | LILACS-Express | LILACS | ID: biblio-1403651

RESUMO

Abstract Duchenne muscular dystrophy (DMD) is an X-linked inherited disorder. Patients present with decreased bone mineral density (BMD) due to glucocorticoid therapy and progressive muscle weakness. Bone remodeling allows bone volume and structure to be maintained and controlled by local and systemic factors. These include the receptor activator of the nuclear factor-kB (RANK)/RANK ligand (RANKL)/osteoprotegerin (OPG) system, a determining pathway in the balance between bone formation and resorption. Disruptions in this complex, caused by factors such as glucocorticoids, can affect bone metabolism. The extensive action of the RANK/RANKL/OPG pathway suggests an influence on dystrophic muscle pathophysiology. This review aimed to highlight some aspects of the RANK/RANKL/OPG system, the effect of glucocorticoids on this pathway, and the pathophysiology of the patient with DMD.


Resumen La distrofia muscular de Duchenne (DMD) es un trastorno hereditario ligado al cromosoma X. Los pacientes presentan una disminución de la densidad mineral ósea (DMO) debido a los efectos adversos del tratamiento con glucocorticoides y a la debilidad muscular progresiva. El remodelado óseo permite mantener el volumen y la estructura ósea, proceso controlado por factores locales y sistémicos. Entre ellos destaca el sistema del receptor activador del factor nuclear-kB (RANK), su ligando natural RANKL (RANKL) y la osteoprotegerina (OPG), una vía determinante en el equilibrio entre la resorción y formación ósea. Las alteraciones en este complejo, originadas por factores como los glucocorticoides, pueden afectar el metabolismo óseo. La amplia acción de RANKL y OPG ha sugerido una influencia en la fisiopatología de la DMD. El objetivo de esta revisión fue destacar algunos aspectos del sistema RANK/RANKL/OPG, el efecto de los glucocorticoides en esta vía y la fisiopatología del paciente con DMD.

10.
Rev. Bras. Neurol. (Online) ; 58(2): 25-30, abr.-jun. 2022. tab, graf
Artigo em Português | LILACS | ID: biblio-1395442

RESUMO

INTRODUCTION: Since December 2019, the scientific community has been mobilized to contain the COVID-19 pandemic. Although individuals with Duchenne Muscular Dystrophy (DMD) have restrictive lung disease, risk of immunosuppression and associated cardiomyopathy, they are not considered to be a risk group for COVID-19. DMD is a neuromuscular, genetic and progressive disease, with early childhood development. In order to manage the disease, multidisciplinary follow-up is necessary to improve this patient's quality of life. OBJECTIVE: Identify the impact of the pandemic on the care of patients with DMD and its repercussions. METHOD: This is a cross-sectional, quantitative and descriptive study. The sample consisted of patients diagnosed with DMD aged between 4 and 18 years, followed up at the neuropediatrics service. Data collection was carried out by an interview with those responsible for the patient and evaluation of the medical records, using a questionnaire. Statistical analysis was descriptive using central tendency and dispersion measures. RESULTS: Among the 44 patients included, the median age was 12 years and the predominant type of gene mutation was deletion (56.8%). The median age of first symptoms was 4 years. Thirteen patients had contact with family members positive for COVID-19 and tested positive for the disease. Eleven received the vaccine against COVID-19. Medical followups suffered a great reduction in the pandemic period, as well as respiratory and motor physiotherapy. CONCLUSION: The pandemic interfered with multidisciplinary care for patients with DMD. As a chronic and degenerative disease, individuals with DMD require ongoing care, which was interrupted by the pandemic scenario.


INTRODUÇÃO: Desde dezembro de 2019, a comunidade científica está mobilizada para a contenção da pandemia pela COVID-19. Embora indivíduos portadores de Distrofia Muscular de Duchenne (DMD) apresentem doença pulmonar restritiva, risco de imunossupressão e cardiomiopatia associada, não são grupo de risco para a COVID-19. DMD é doença neuromuscular, genética e progressiva, de início na infância. Para manejo da doença, faz-se necessário acompanhamento multidisciplinar para melhora da qualidade de vida. OBJETIVO: Identificar o impacto da pandemia nos cuidados aos pacientes com DMD e suas repercussões. MÉTODOS: Trata-se de um estudo transversal, quantitativo e descritivo. A amostra foi composta por pacientes com diagnóstico de DMD com idade entre 4 e 18 anos acompanhados no serviço de neuropediatria. A coleta de dados foi realizada por entrevista com responsáveis e avaliação do prontuário, a partir de um questionário. A análise estatística foi descritiva com uso de medida de tendência central e dispersão. RESULTADOS: Dentre os 44 pacientes incluídos, a mediana de idade foi de 12 anos e o tipo de mutação gênica predominante a deleção (56,8%). A mediana de idade dos primeiros sintomas foi de 4 anos. Treze pacientes tiveram contato com familiares positivos para COVID-19 e testaram positivo para a doença. Onze receberam a vacina contra COVID-19. Os acompanhamentos médicos sofreram grande redução no período pandêmico, bem como a fisioterapia respiratória e motora. CONCLUSÃO: A pandemia interferiu nos atendimentos multidisciplinares aos pacientes com DMD. Como uma doença crônica e degenerativa, os indivíduos com DMD necessitam de cuidados contínuos, o que foi interrompido pelo cenário pandêmico.


Assuntos
Humanos , Pré-Escolar , Criança , Adolescente , Equipe de Assistência ao Paciente , Distrofia Muscular de Duchenne/diagnóstico , Distrofia Muscular de Duchenne/terapia , Suspensão de Tratamento , Pandemias , COVID-19/prevenção & controle , Estudos Transversais , Inquéritos e Questionários
11.
Medicina (B.Aires) ; 82(2): 209-210, mayo 2022. graf
Artigo em Inglês | LILACS-Express | LILACS | ID: biblio-1375862

RESUMO

Abstract There are few data devoted to the combined assessment of the nutritional and respiratory status of subjects with neuromuscular diseases. The objective was to establish correlations between com partmental nutritional variables and respiratory variables to identify respiratory muscle weakness determinants of patients with amyotrophic lateral sclerosis (ALS) and Duchenne muscular dystrophy (DMD). Cross-sectional study with ALS and DMD patients included in an Institutional Registry of Neuromuscular diseases. Nutritional status was assessed through body mass index (BMI), expected weight for zero muscle mass (ZMM%) and creatinine-height index (CHI%). Respiratory indices evaluated were spirometry, maximal static inspiratory and expiratory pressures at the mouth (MIP and MEP), and peak cough flow (PCF). A total of 36 ALS and 34 DMD patients were included. Both groups showed a decrease in the body muscle mass and an excess in body fat (p < 0.001). Only in the ALS group was there a weak uphill relationship between body mass index (BMI) and the respiratory variables. In both groups, the ZMM% index did not correlate with any respiratory variable. The CHI% showed the strongest (r > 0.700) positive linear relationship with FVC%, MIP%, MEP%, and PCF% in both ALS and DMD patients (p < 0.001).In this study our patients, BMI did not accurately reflect body composition and underestimated excess fat. This study puts into perspective the relevance of compartmental evaluation to assess respiratory muscle function and establishes that body muscle mass is the most relevant nutritional parameter in relation to respiratory muscle strength.


Resumen Hay pocos datos relativos a la evaluación combinada del estado nutricional y respiratorio de sujetos con enfermedades neuromusculares. El objetivo fue establecer correlaciones entre las variables nutricionales compartimentales y las variables respiratorias para identificar los determinantes de la debilidad de los músculos respiratorios de los pacientes con esclerosis lateral amiotrófica (ELA) y distrofia muscular de Duchenne (DMD). Estudio transversal con pacientes con ELA y DMD incluidos en el Registro Institucional de Enfermedades Neuromusculares. El estado nutricional se evaluó mediante el índice de masa corporal (IMC), el peso esperado para masa muscular cero (ZMM%) y el índice de creatinina-talla (CHI%). Los índices respiratorios evaluados fueron espirometría, presiones inspiratorias y espiratorias estáticas máximas en la boca (MIP y MEP) y flujo espiratorio pico tosido (PCF). Se incluyeron un total de 36 pacientes con ELA y 34 con DMD. Ambos grupos mostraron una disminución de la masa muscular corporal y un exceso de grasa corporal (p <0.001). Solo en el grupo ELA hubo una débil correlación positiva entre el IMC y las variables respiratorias. En ambos grupos, el índice ZMM% no se correlacionó con ninguna variable respiratoria. El CHI% mostró la relación lineal positiva más fuerte (r > 0.700) con FVC%, MIP%, MEP% y PCF% tanto en pacientes con ELA como con DMD (p < 0.001). El IMC no reflejó con precisión la composición corporal y subestimó el exceso de grasa. Este estudio pone en perspectiva la relevancia de la evaluación compartimental para evaluar la función de la musculatura respiratoria y establece que la masa muscular corporal es el parámetro nutricional más relevante en relación a la fuerza de la musculatura respiratoria.

12.
Artigo | IMSEAR | ID: sea-222174

RESUMO

Patients suffering from Duchenne Muscular Dystrophy (DMD) are at higher risk of suffering significant morbidity resulting from COVID-19, considering their pre-existing respiratory insufficiency and immunocompromised state. We present such a case who was admitted to our intensive care unit. A 21-year-old patient, who was a diagnosed case of DMD since the age of 8 and on treatment with steroids, angiotensin-converting enzyme inhibitors, and intermittent home-oxygen support, presented with fever and breathlessness and was diagnosed to have COVID-19 pneumonia. Oxygen support was provided by non-invasive ventilation (NIV), along with therapeutic and supportive treatment, namely, azithromycin, remdesivir, dexamethasone, and heparin. Dyselectrolytemia was corrected and convalescent plasma was transfused. The patient was weaned off NIV and discharged on significant improvement in his general condition. Although the treatment of COVID-19 using convalescent plasma has now fallen out of favor, we found some clinical improvement in our patient. DMD complicated by COVID-19 can seem like a daunting challenge, but providing fundamental, yet, simple treatment measures goes a long way in the patient care

13.
Chinese Journal of Applied Clinical Pediatrics ; (24): 1516-1520, 2022.
Artigo em Chinês | WPRIM | ID: wpr-954785

RESUMO

Duchenne muscular dystrophy (DMD) is a disease inherited in an X-linked recessive pattern, which is caused by the pathogenic mutation of the gene encoding Dystrophin.An increasing number of studies have confirmed the high risk of neurodevelopmental disorders in children with DMD, and that related comorbidities have distinct clinical characteristics.In this article, the research progress on neurodevelopmental disorders in children with DMD was reviewed to clarify the prevalence, clinical characteristics and high-risk factors of neurodevelopmental disorders in children with DMD.DMD therapy teams should pay attention to the evaluation, interpretation and early intervention of neurodevelopmental disorders in clinic practice, so as to improve the life quality of DMD children and help them to be-tter integrate into the society.

14.
Chinese Journal of Applied Clinical Pediatrics ; (24): 954-957, 2022.
Artigo em Chinês | WPRIM | ID: wpr-954670

RESUMO

Duchenne muscular dystrophy(DMD) is an X-linked hereditary neuromuscular disorder caused by dystrophin gene mutation.About 1/3 of DMD patients have cognitive impairment.Early detection of cognitive impairment is essential for early diagnosis and the quality of life.This review summarized the recent progress in the clinical features, pathogenesis, brain structure changes, and cognitive impairment intervention of DMD.

15.
JOURNAL OF RARE DISEASES ; (4): 199-205, 2022.
Artigo em Inglês | WPRIM | ID: wpr-1005002

RESUMO

In recent years, antisense oligonucleotide (ASO) has been very active in the field of rare disease research and development, especially in Duchenne muscular dystrophy, where it made a major breakthrough. Duchenne muscular dystrophy (DMD) is a rare childhood myopathy caused by mutations in the dystrophin gene. Currently, the four ASO drugs approved internationally for DMD are all targeted at dystrophin, including eteplirsen, golodirsen, viltolarsen and casimersen. They all belong to phosphorodiamidate morpholino oligomers (PMO) antisense oligonucleotide drugs, so that their pharmacokinetic characteristics are similar. The drugs quickly spread to other tissues after intravenous administration. Because of the electrical neutrality of the PMO, they have a low binding rate to plasma proteins and are quickly metabolized by the kidney and excreted in the urine as archetypes. In addition, the likelihood of drug-drug interactions of ASO is low. Existing clinical studies have shown that they have certain clinical benefits and good tolerability, bringing new options for DMD treatment. This paper mainly discusses the pharmacological effects, pharmacokinetic characteristics, efficacy, and safety of ASO drugs for the treatment of DMD, hoping to provide scientific reference for the rational and safe clinical use of such drugs.

16.
Medisan ; 25(4)2021. ilus
Artigo em Espanhol | LILACS, CUMED | ID: biblio-1340212

RESUMO

Se presenta el caso clínico de un adolescente de 18 años de edad, atendido en el Policlínico Docente Armando García Aspurú de Santiago de Cuba por presentar antecedentes de retardo en el desarrollo psicomotor, marcha anadeante, caídas frecuentes, signo de Gowers positivo, fuerza muscular proximal disminuida en miembros superiores e inferiores, pseudohipertrofia de los gemelos, atrofia de cuádriceps pectoral y escapular. Los signos y síntomas clínicos permitieron diagnosticar una distrofia muscular de Duchenne. Como no pudo realizarse el tratamiento rehabilitador necesario, se produjo un deterioro músculo - esquelético progresivo y severo del paciente.


The case report of an 18 years adolescent is presented. He was assisted at Armando García Aspurú Teaching Polyclinic in Santiago de Cuba due to a history of psychomotor development retardation, wandering march, frequent falls, positive Gowers sign, diminished proximal muscular force in upper and lower limbs, twins pseudohypertrophy, atrophy of pectoralis and scapular quadriceps. The clinical signs and symptoms allowed to diagnose a Duchenne muscular dystrophy. As the necessary rehabilitative treatment could not be carried out, a progressive and severe musculoskeletal deterioration of the patient took place.


Assuntos
Distrofia Muscular de Duchenne/diagnóstico , Distrofia Muscular de Duchenne/reabilitação , Deficiências do Desenvolvimento/diagnóstico , Adolescente , Músculos/patologia
17.
Interdisciplinaria ; 38(3): 221-238, jun. 2021. tab, graf
Artigo em Espanhol | LILACS-Express | LILACS | ID: biblio-1356337

RESUMO

Resumen La Distrofia Muscular de Duchenne (DMD) es una enfermedad neuromuscular, clasificada como una enfermedad huérfana o rara, transmitida por la madre, y que conlleva al deterioro físico progresivo y fatal de quienes la desarrollan, que en su mayoría son hombres. Aun con los tratamientos farmacológicos disponibles, el pronóstico de vida de los pacientes sigue siendo desalentador. Los niños van perdiendo progresivamente la movilidad y funcionalidad hasta que fallecen. En consecuencia, el progreso de esta enfermedad requiere de cuidados frecuentes o permanentes que implican altos niveles de exigencia para las cuidadoras de niños y de jóvenes que han desarrollado la DMD. El apoyo proveniente del sistema de salud es escaso para ambos, lo que se traduce en una intensa sobrecarga para las madres y mujeres de la familia que son quienes, habitualmente, cuidan a la persona diagnosticada con DMD durante su vida. Este estudio cualitativo de tipo fenomenológico tuvo como objetivos analizar el significado de la experiencia de ser cuidadora de niños y jóvenes que viven con DMD en Colombia, develando el sentido que tiene para las mujeres familiares asumir el rol de cuidadora. Se entrevistaron siete mujeres entre los 25 y los 64 años encargadas de cuidar, por lo menos, a un niño o joven con diagnóstico de DMD, previo consentimiento informado. Adicionalmente, los cuidadores desarrollaron un ejercicio de asociaciones libres. Para el análisis de datos se realizó un análisis temático de las narrativas, encontrando tres temas fundamentales alrededor de los cuales se le da sentido a esta experiencia: (1) descubrir la enfermedad, (2) vivir en función del paciente y (3) reconstruir el sentido de vida. Así, en un momento inicial las cuidadoras se enfrentan al diagnóstico de la enfermedad brindado por los médicos, quienes les explican su curso y su naturaleza. La cuidadora inicia un proceso de duelo, en el que la tristeza, la negación y la resignación tienen lugar, y emociones como la frustración y la impotencia se presentan en su máxima expresión. La manera en la que es comunicado el diagnóstico es evaluada por las cuidadoras como poco sensible. De hecho, ninguna de las participantes en el estudio recibió apoyo psicológico durante el proceso. En segundo lugar, ser la figura de cuidado implicó cambios a nivel personal, familiar y social, para lograr responder a las necesidades de los niños con DMD. En este sentido, algunas debieron renunciar a sus empleos, alejarse de amistades e incluso algunas manifestaron que se han separado de su pareja o han vivido experiencias de deterioro en las relaciones con su pareja y familia extensa. Además, junto con sus hijos han vivenciado experiencias de discriminación, vulneración de derechos y escaso apoyo social, experiencias que son factores de riesgo para la salud mental. Finalmente, la enfermedad termina por constituirse en el elemento vinculante entre ellas y sus niños. Los hallazgos de la presente investigación permiten identificar que, en el proceso de enfermedad, se produce una reconstrucción del sentido de vida. Así, las estrategias de afrontamiento se dirigen a lograr una transformación espiritual. La presencia de la enfermedad es interpretada como una manera de ser probadas y desarrollar sus cualidades como mujer y como madre. Entonces, el cuidado y la relación madre-hijo, son componentes motivacionales que transforman y dan sentido a la vida. En conclusión, los resultados muestran que el significado de la DMD está fuertemente vinculado a un proceso de intenso sufrimiento y estrés psicológico, con alta carga negativa. En particular, durante los primeros años después del diagnóstico, que debe ser asimilado y elaborado para aprender a convivir con la DMD y la certeza de la muerte prematura de un hijo.


Abstract Duchenne muscular dystrophy (DMD) is a neuromuscular disease that leads to progressive and fatal physical deterioration. The progression of this disease requires frequent or permanent care that implies high levels of demand for the caregivers of children who have developed DMD. Certainly, this disease affects diagnosed children and their caregivers as well. The support from the health system is scarce for both, which translates into an intense burden for the mothers and women of the family who care the person diagnosed with DMD during their lifetime. This qualitative study with phenomenological approach aimed to analyze the meaning of the experience of being a caregiver for boys and young men living with DMD in Colombia. After obtaining their informed consent, caregivers were interviewed and a thematic analysis of their narratives was performed to determine three key topics that endow their experiences with meaning: (1) finding out about the disease, (2) living according to the needs of boys and young men, and (3) providing a new meaning to life. The results show that the meaning of DMD is strongly associated with intense suffering and psychological stress, with a high negative burden, especially during the initial years after diagnosis. The study suggests that it is important to assimilate and process these experiences and findings to learn how to live with DMD and identify the certainty of a child's premature death.

18.
Rev. bras. neurol ; 57(1): 30-38, jan.-mar. 2021. tab
Artigo em Português | LILACS | ID: biblio-1177699

RESUMO

OBJETIVO: Pesquisar as recomendações nutricionais para pacientes com Distrofia Muscular de Duchenne (DMD). MÉTODO: Trata- se de uma revisão integrativa da literatura, através de levantamento bibliográfico nas bases cientificas PubMed e Scielo, foram utilizadas as palavras chaves: Distrofia Muscular de Duchenne em combinação com os termos Nutrição, Nutrientes, Nutracêuticos, Vitaminas e Antioxidantes. Foi realizada a busca dos artigos publicados nos últimos 10 anos. RESULTADOS: Foram selecionados 102 artigos, dos quais após análise dos critérios de exclusão e inclusão, resultaram em 31 artigos referentes a 31,62% da amostra inicial que foram utilizados para a produção dessa revisão. CONCLUSÃO: O acompanhamento nutricional do paciente com DMD é fundamental, de forma a garantir a manutenção do estado nutricional, além de contribuir de forma significativa para a desaceleração dos sintomas da doença e melhora da qualidade de vida.


OBJECTIVE: To search for nutritional recommendations for patients with Duchenne Muscular Dystrophy (DMD). METHOD: It is an integrative review of the literature, through a bibliographic survey on the scientific bases PubMed and Scielo, the keywords used were Duchenne Muscular Dystrophy in combination with the terms Nutrition, Nutrients, Nutraceuticals, Vitamins and Antioxidants. The search was based on articles published in the last 10 years. RESULTS: A total of 102 articles were selected, of which, after analyzing the exclusion and inclusion criteria, resulted in 32 articles referring to 32.64% of the initial sample that were used to produce this review. CONCLUSION: Nutritional monitoring of patients with DMD is essential, in order to guarantee the maintenance of nutritional status, in addition to contributing significantly to the deceleration of the symptoms of the disease and improving the quality of life.


Assuntos
Humanos , Masculino , Pré-Escolar , Criança , Adolescente , Vitaminas/administração & dosagem , Distrofia Muscular de Duchenne/diagnóstico , Distrofia Muscular de Duchenne/dietoterapia , Terapia Nutricional/métodos , Recomendações Nutricionais , Estado Nutricional , Antioxidantes
19.
Psicol. USP ; 32: e190171, 2021. graf
Artigo em Inglês | LILACS, INDEXPSI | ID: biblio-1155148

RESUMO

Abstract Duchenne muscular dystrophy (DMD) is a chronic disease that primarily affects males and is characterized by progressive physical impairment and, eventually, death. This qualitative study aimed to explore and understand the experience of diagnosis and disease in young people with DMD living in Bogotá, Colombia. After securing approval from the Research Ethics Committee (CEI-ABN026-000311), nine individuals took part of a semi-structured interview, and their narratives were analyzed using thematic analysis. The main topics developed throughout the narratives were: negative representation of the disease; fear; difficulty expressing emotions; the patient-doctor relationship; the wheelchair; the caregivers and coping strategies. We conclude that young people affected by DMD face several challenging experiences that underscore the need for better, more respectful, and compassionate interactions with healthcare providers. Also, their experiences are indicative of a socio-cultural context that needs to become more responsive and compassionate towards young people and disability.


Resumo A distrofia muscular de Duchenne (DMD) é uma doença crônica que afeta principalmente os homens, caracterizada pelo deterioro físico progressivo e por conduzir à morte. Este estudo qualitativo teve como objetivo a exploração e a compreensão da experiência do diagnóstico e da doença em jovens com DMD residentes em Bogotá, Colômbia. Após a aprovação do Comitê de Ética em Pesquisa (CEI-ABN026-000311), nove participantes participaram numa entrevista semiestruturada e as suas narrativas foram analisadas através da análise temática. Os principais temas abordados foram: a representação negativa da doença; o medo; a dificuldade em expressar emoções; a relação paciente-médico; a cadeira de rodas; os cuidadores e as estratégias de resiliência. Concluímos que os jovens afetados pela DMD enfrentam experiências desafiantes que evidenciam a necessidade de interações melhores, mais respeitosas e compassivas com os profissionais de saúde. Ao mesmo tempo, as suas experiências são indicativas de um contexto sociocultural que precisa de se tornar mais recetivo e compassivo para com os jovens e as deficiências.


Résumé La Dystrophie Musculaire de Duchenne (DMD) est une maladie chronique qui touche principalement les hommes et se caractérise par détérioration physique progressive et, éventuellement, la mort. Cette rechérche qualitative a explorer l'expérience du diagnostic et de la maladie chez les jeunes atteints de DMD à Bogotá, Colombie. Cette rechérche a été évaluée et approuvée par un comité d'éthique de la recherche (CEI-ABN026-000311). Neuf jeunes ont participé à un entretien semi-structuré et leurs récits ont été analysés à l'aide d'une analyse thématique. Les principaux thèmes développés dans les récits étaient: la représentation négative de la maladie; peur; difficulté à exprimer ses émotions; la relation médecin-patient; le fauteuil roulant; soignants et stratégies d'adaptation. Nous concluons que les jeunes touchés par la DMD vivent de multiples expériences difficiles qui mettent en évidence la nécessité d'interactions plus respectueuses et plus compatissantes avec les prestataires de services de santé. En même temps, leurs expériences montrent un contexte socioculturel qui doit être plus sensible et compatissant envers les enfants et les jeunes handicapés.


Resumen La distrofia muscular de Duchenne (DMD) es una enfermedad crónica que afecta principalmente a hombres y se caracteriza por deterioro físico progresivo y, eventualmente, la muerte. Este estudio cualitativo buscó explorar y comprender la experiencia del diagnóstico y la enfermedad en jóvenes con DMD en la ciudad de Bogotá, Colombia. Tras recibir autorización del Comité de Ética en Investigación (CEI-ABN026-000311), nueve participantes colaboraron con una entrevista semiestructurada y sus narrativas fueron analizadas usando análisis temático. Los principales temas desarrollados en las narrativas fueron: representación negativa de la enfermedad; miedo; dificultad expresando emociones; la relación médico-paciente; la silla de ruedas; los cuidadores y las estrategias de afrontamiento. Concluimos que los jóvenes afectados por la DMD enfrentan múltiples experiencias retadoras que hacen evidente la necesidad de interacciones más respetuosas y compasivas con los proveedores de servicios de salud. Al mismo tiempo, sus experiencias muestran un contexto sociocultural que necesita ser más sensible y compasivo con los niños y jóvenes en situación de discapacidad.


Assuntos
Humanos , Masculino , Criança , Adolescente , Adulto , Distrofia Muscular de Duchenne/psicologia , Colômbia , Acontecimentos que Mudam a Vida
20.
Rev. Pesqui. (Univ. Fed. Estado Rio J., Online) ; 13: 547-552, jan.-dez. 2021. tab
Artigo em Inglês, Português | LILACS, BDENF | ID: biblio-1222542

RESUMO

Objetivo: Relacionar a capacidade funcional de pacientes com Distrofia Muscular de Duchenne com a sobrecarga dos seus cuidadores familiares. Métodos: Estudo transversal com amostra composta por 35 pacientes e seus cuidadores familiares, de um centro de reabilitação de Goiânia-GO. Foram utilizados para avaliação da capacidade funcional a Escala de Vignos, Medida da Função Motora, Índice de Barthel e Escala Egen Klassification e para avaliação da sobrecarga o Burden Interview. Resultados: Os cuidadores estavam com sobrecarga moderada, com média de 23,6 (±10,3). A pontuação média dos instrumentos demonstrou que os pacientes estavam em fase avançada de estadiamento da doença e prejuízo da capacidade funcional. Não foi encontrada relação significativa entre a sobrecarga dos cuidadores e a capacidade funcional dos pacientes. Conclusão: O cuidador está diretamente ligado à função de zelar do paciente, portanto a equipe multiprofissional precisa se atentar também à saúde mental deste, oferecendo suporte para intervenções especializadas


Objective: To relate a functional capacity of patients with Duchenne muscular dystrophy to the burden of their family caregivers. Methods: A cross-sectional study with 35 patients and their family caregivers from a rehabilitation center in Goiânia-GO. Were used for the functional evaluation of the Vignos Scale, Motor Function Measure Scale, Barthel Index, Egen Klassification Scale and for burden evaluation the Burden Interview. Results: The caregivers had moderate burden, with a mean of 23,6 (± 10,3). Regarding the patients, the average score of the instruments showed that they were in an advanced stage of disease staging and impairment of functional capacity. No significant relationship was found between the caregiver burden and the patient's functional capacity. Conclusion: The caregiver is directly connected to the care function of the patient, so the multiprofessional team needs to pay attention to their mental health, offering support for specialized interventions


Objetivo: Relacionar la capacidad funcional de pacientes con Distrofia Muscular de Duchenne con la sobrecarga de sus cuidadores familiares. Métodos: Estudio transversal con muestra compuesta por 35 pacientes y sus cuidadores familiares, de un centro de rehabilitación de Goiânia-GO. Se utilizaron para la evaluación de la capacidad funcional la Escala de Vignos, Medida de la Función Motora, Índice de Barthel y Escala Egen Klassification y para evaluación de la sobrecarga el Burden Interview. Resultados: La sobrecarga de los cuidadores fue considerada moderada, con promedio de 23,6 (± 10,3). En cuanto a los pacientes, la puntuación media de los instrumentos demostró que estaban en fase avanzada de estadificación de la enfermedad y perjuicio de la capacidad funcional. No se encontró una relación significativa entre la sobrecarga de los cuidadores y la capacidad funcional de los pacientes. Conclusión: El cuidador está directamente ligado a la función de velar del paciente, por lo tanto el equipo multiprofesional necesita atenderse también a la salud mental de éste, ofreciendo soporte para intervenciones especializadas


Assuntos
Humanos , Masculino , Feminino , Equipe de Assistência ao Paciente , Cuidadores/psicologia , Distrofia Muscular de Duchenne , Esgotamento Psicológico
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA